This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1995;18(2):123-6.

doi: 10.1007/BF00711745.

Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC

S Bird¹, N J Miller, J E Collins, C A Rice-Evans

Affiliations

PMID: 7564225
DOI: 10.1007/BF00711745

Case Reports

Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC

S Bird et al. J Inherit Metab Dis. 1995.

. 1995;18(2):123-6.

doi: 10.1007/BF00711745.

Authors

S Bird¹, N J Miller, J E Collins, C A Rice-Evans

Affiliation

¹ Clinical Biochemistry Department, UMDS, Guy's Hospital, London, UK.

PMID: 7564225
DOI: 10.1007/BF00711745

No abstract available

PubMed Disclaimer

Similar articles

NTBC as palliative treatment in chronic tyrosinaemia type I.
Ros J, Vilaseca MA, Lambruschini N, Mas A, Lindstedt S, Holme E. Ros J, et al. J Inherit Metab Dis. 1999 Jun;22(5):665-6. doi: 10.1023/a:1005594416973. J Inherit Metab Dis. 1999. PMID: 10399099 No abstract available.
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).
Pronicka E, Rowinska E, Bentkowski Z, Zawadzki J, Holme E, Lindstedt S. Pronicka E, et al. J Inherit Metab Dis. 1996;19(2):234-8. doi: 10.1007/BF01799438. J Inherit Metab Dis. 1996. PMID: 8739974 No abstract available.
NTBC and alkaptonuria.
Anikster Y, Nyhan WL, Gahl WA. Anikster Y, et al. Am J Hum Genet. 1998 Sep;63(3):920-1. doi: 10.1086/302027. Am J Hum Genet. 1998. PMID: 9718357 Free PMC article. No abstract available.
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
Holme E, Lindstedt S. Holme E, et al. J Inherit Metab Dis. 1998 Aug;21(5):507-17. doi: 10.1023/a:1005410820201. J Inherit Metab Dis. 1998. PMID: 9728331 Review.
From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.
Lock EA, Ellis MK, Gaskin P, Robinson M, Auton TR, Provan WM, Smith LL, Prisbylla MP, Mutter LC, Lee DL. Lock EA, et al. J Inherit Metab Dis. 1998 Aug;21(5):498-506. doi: 10.1023/a:1005458703363. J Inherit Metab Dis. 1998. PMID: 9728330 Review.

See all similar articles

Cited by

Current strategies for the treatment of hereditary tyrosinemia type I.
Ashorn M, Pitkänen S, Salo MK, Heikinheimo M. Ashorn M, et al. Paediatr Drugs. 2006;8(1):47-54. doi: 10.2165/00148581-200608010-00004. Paediatr Drugs. 2006. PMID: 16494511 Review.
Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats.
Macêdo LG, Carvalho-Silva M, Ferreira GK, Vieira JS, Olegário N, Gonçalves RC, Vuolo FS, Ferreira GC, Schuck PF, Dal-Pizzol F, Streck EL. Macêdo LG, et al. Neurochem Res. 2013 Dec;38(12):2625-30. doi: 10.1007/s11064-013-1180-3. Epub 2013 Oct 18. Neurochem Res. 2013. PMID: 24135880
The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.
Wajner M, Latini A, Wyse AT, Dutra-Filho CS. Wajner M, et al. J Inherit Metab Dis. 2004;27(4):427-48. doi: 10.1023/B:BOLI.0000037353.13085.e2. J Inherit Metab Dis. 2004. PMID: 15303000 Review.
Profiling of oxidative stress in patients with inborn errors of metabolism.
Mc Guire PJ, Parikh A, Diaz GA. Mc Guire PJ, et al. Mol Genet Metab. 2009 Sep-Oct;98(1-2):173-80. doi: 10.1016/j.ymgme.2009.06.007. Epub 2009 Jun 14. Mol Genet Metab. 2009. PMID: 19604711 Free PMC article.
Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.
Grompe M, Overturf K, al-Dhalimy M, Finegold M. Grompe M, et al. J Inherit Metab Dis. 1998 Aug;21(5):518-31. doi: 10.1023/a:1005462804271. J Inherit Metab Dis. 1998. PMID: 9728332

See all "Cited by" articles

References

1. Lancet. 1992 Oct 3;340(8823):813-7 - PubMed
1. N Engl J Med. 1990 Feb 15;322(7):432-7 - PubMed
1. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641-5 - PubMed
1. Clin Sci (Lond). 1993 Apr;84(4):407-12 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information